1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. CRISPR THERAPEUTICS AG
CRISPR Therapeutics AG XNAS: CRSP

CRISPR Therapeutics AG Live Share Price Today, Share Analysis and Chart

Momentum Trap
about

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revol...

Read More
52.73 -3.69 (-6.54%)
75.53% Gain from 52W Low
3.1M
XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
9.2 / 100
Momentum Score
Technically Moderately Bullish
63.0 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
82
1Yr Price target upside is 55%
24 analysts

14

S

8

W

2

O

1

T

SWOT Analysis

CRISPR Therapeutics AG Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..